SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 75 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $34,929,348 | -34.9% | 39,423,641 | +15.3% | 0.00% | -50.0% |
| Q3 2022 | $53,664,000 | -21.4% | 34,179,567 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $68,242,000 | +32.9% | 33,950,557 | +54.1% | 0.00% | +100.0% |
| Q1 2022 | $51,341,000 | -49.3% | 22,034,889 | +1.2% | 0.00% | -66.7% |
| Q4 2021 | $101,258,000 | -36.4% | 21,775,865 | +4.4% | 0.00% | -25.0% |
| Q3 2021 | $159,218,000 | -14.1% | 20,867,671 | +9.2% | 0.00% | -20.0% |
| Q2 2021 | $185,253,000 | +15.4% | 19,117,922 | -1.5% | 0.01% | 0.0% |
| Q1 2021 | $160,515,000 | +33.5% | 19,409,333 | +10.2% | 0.01% | +25.0% |
| Q4 2020 | $120,253,000 | -28.2% | 17,619,678 | +17.3% | 0.00% | -33.3% |
| Q3 2020 | $167,434,000 | +112.6% | 15,016,558 | +19.8% | 0.01% | +100.0% |
| Q2 2020 | $78,745,000 | +386.9% | 12,539,053 | +42.6% | 0.00% | +200.0% |
| Q1 2020 | $16,173,000 | -44.6% | 8,790,097 | +1.7% | 0.00% | 0.0% |
| Q4 2019 | $29,214,000 | +68.5% | 8,643,058 | +6.7% | 0.00% | 0.0% |
| Q3 2019 | $17,336,000 | -16.9% | 8,100,682 | +3.7% | 0.00% | 0.0% |
| Q2 2019 | $20,855,000 | -41.8% | 7,810,546 | +3.5% | 0.00% | -50.0% |
| Q1 2019 | $35,845,000 | +97.4% | 7,546,509 | -0.3% | 0.00% | +100.0% |
| Q4 2018 | $18,158,000 | -44.8% | 7,566,238 | +1.3% | 0.00% | 0.0% |
| Q3 2018 | $32,871,000 | -24.4% | 7,470,822 | +23.7% | 0.00% | -50.0% |
| Q2 2018 | $43,500,000 | +286.3% | 6,041,652 | +176.3% | 0.00% | +100.0% |
| Q1 2018 | $11,262,000 | +206.0% | 2,186,936 | +125.9% | 0.00% | – |
| Q4 2017 | $3,680,000 | +224.5% | 968,284 | +45.0% | 0.00% | – |
| Q3 2017 | $1,134,000 | +12.7% | 667,766 | +32.8% | 0.00% | – |
| Q2 2017 | $1,006,000 | -83.8% | 502,683 | -68.0% | 0.00% | – |
| Q1 2017 | $6,201,000 | +61910.0% | 1,569,502 | +78532.4% | 0.00% | – |
| Q4 2016 | $10,000 | -44.4% | 1,996 | -13.9% | 0.00% | – |
| Q3 2016 | $18,000 | -58.1% | 2,318 | -69.3% | 0.00% | – |
| Q2 2016 | $43,000 | +330.0% | 7,546 | +310.8% | 0.00% | – |
| Q1 2016 | $10,000 | -37.5% | 1,837 | +4.9% | 0.00% | – |
| Q4 2015 | $16,000 | +220.0% | 1,752 | +168.7% | 0.00% | – |
| Q3 2015 | $5,000 | -54.5% | 652 | 0.0% | 0.00% | – |
| Q2 2015 | $11,000 | – | 652 | +5333.3% | 0.00% | – |
| Q1 2014 | $0 | – | 12 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |